These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 23080224)
1. Effectiveness and safety of antiplatelet therapy in stroke recurrence prevention in patients with liver cirrhosis: a 2-year follow-up study. Chen CY; Lee KT; Lee CT; Lai WT; Huang YB Pharmacoepidemiol Drug Saf; 2012 Dec; 21(12):1334-43. PubMed ID: 23080224 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of antiplatelet in stroke patients with end-stage renal disease undergoing dialysis. Chen CY; Lee KT; Lee CT; Lai WT; Huang YB Int J Stroke; 2014 Jul; 9(5):580-90. PubMed ID: 24597578 [TBL] [Abstract][Full Text] [Related]
3. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected]. Kirshner HS Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660 [TBL] [Abstract][Full Text] [Related]
4. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling? Diener HC Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062 [TBL] [Abstract][Full Text] [Related]
5. Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors. Burke JP; Sander S; Shah H; Zarotsky V; Henk H Curr Med Res Opin; 2010 May; 26(5):1023-30. PubMed ID: 20199138 [TBL] [Abstract][Full Text] [Related]
6. High prevalence of previous antiplatelet drug use in patients with new or recurrent ischemic stroke: Buffalo metropolitan area and Erie County stroke study. Qureshi AI; Kirmani JF; Safdar A; Ahmed S; Sayed MA; Pande RU; Ferguson R; Hershey LA; Qazi KJ Pharmacotherapy; 2006 Apr; 26(4):493-8. PubMed ID: 16553507 [TBL] [Abstract][Full Text] [Related]
7. Coronary artery stents and antiplatelet therapy in patients with cirrhosis. Russo MW; Pierson J; Narang T; Montegudo A; Eskind L; Gulati S J Clin Gastroenterol; 2012 Apr; 46(4):339-44. PubMed ID: 22105182 [TBL] [Abstract][Full Text] [Related]
8. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding. Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493 [TBL] [Abstract][Full Text] [Related]
9. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P; N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192 [TBL] [Abstract][Full Text] [Related]
11. Review and management of side effects associated with antiplatelet therapy for prevention of recurrent cerebrovascular events. Guthrie R Adv Ther; 2011 Jun; 28(6):473-82. PubMed ID: 21547541 [TBL] [Abstract][Full Text] [Related]
12. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines. Hankey GJ Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741 [TBL] [Abstract][Full Text] [Related]
13. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy. Biller J J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study. Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481 [TBL] [Abstract][Full Text] [Related]
15. Net clinical benefit of adding clopidogrel to aspirin therapy in patients with atrial fibrillation for whom vitamin K antagonists are unsuitable. Connolly SJ; Eikelboom JW; Ng J; Hirsh J; Yusuf S; Pogue J; de Caterina R; Hohnloser S; Hart RG; Ann Intern Med; 2011 Nov; 155(9):579-86. PubMed ID: 22041946 [TBL] [Abstract][Full Text] [Related]
16. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use. Reaume KT; Regal RE; Dorsch MP Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394 [TBL] [Abstract][Full Text] [Related]
17. An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial. Wang TH; Bhatt DL; Fox KA; Steinhubl SR; Brennan DM; Hacke W; Mak KH; Pearson TA; Boden WE; Steg PG; Flather MD; Montalescot G; Topol EJ; Eur Heart J; 2007 Sep; 28(18):2200-7. PubMed ID: 17673448 [TBL] [Abstract][Full Text] [Related]
18. Update on aspirin in the treatment and prevention of cardiovascular disease. Hennekens CH Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736 [TBL] [Abstract][Full Text] [Related]
19. Current status of antiplatelet treatment before and after ischemic stroke, and an analysis of factors associated with antiplatelet treatment, in the Qingdao area of China. Wang X; Wang P; Yu TF; Zhang M; DU ZQ; Xing CM Chin Med J (Engl); 2011 Dec; 124(24):4254-9. PubMed ID: 22340395 [TBL] [Abstract][Full Text] [Related]
20. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Lee MS; Smith SD; Galor A; Hoffman GS Arthritis Rheum; 2006 Oct; 54(10):3306-9. PubMed ID: 17009265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]